drugset / Trial / NCT04921878
A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK) and efficacy of mitoxantrone hydrochloride liposome injection in patients with advanced solid tumors.
Timeline
- Start
- 2021-07-30
- Primary completion
- 2023-04-03
- Completion
- 2023-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mitoxantrone | Small molecule | 24 mg/m2 | Intravenous |
| Subject | Mitoxantrone | Small molecule | 30 mg/m2 | Intravenous |
| Subject | Mitoxantrone | Small molecule | 36 mg/m2 | Intravenous |
| Subject | Mitoxantrone | Small molecule | 40 mg/m2 | Intravenous |